Bevespi Aerosphere FDA Approved Drugs
BEVESPI AEROSPHERE [Formoterol Fumarate2C19H24N2O4C4H4O42H2O : GlycopyrrolateC19H28NO3Br]
0.0048mg/inh : 0.0090mg/inh (inhalation aerosol, metered)
Astrazeneca PharmsApr 25, 2016
- Use in the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.